Audi plans to launch an affordable electric car as early as next year. It was previously only planned for 2027. According to ...
St. Christopher's Hospital for Children, a nationally recognized leader in pediatric health care, medical training and research, today kicked off a celebration of its 150th anniversary. The milestone, ...
12h
News Medical on MSNReduced-dose apixaban proves effective in preventing blood clot recurrence in cancer patientsPatients with active cancer who developed a blood clot, or venous thromboembolism (VTE), and were treated with blood-thinning medication for at least six months, followed by an additional 12 months of ...
MG Motor India starts accepting pre-bookings for its premium CBU electric models, Cyberster and M9. Customers can book these models with a refundable token of Rs 51,000 at select dealerships and ...
1h
News-Medical.Net on MSNCaffeine and beetroot juice beat fatigue in repeated high-intensity runsCaffeine combined with beetroot juice significantly improves both initial and repeated 1000-meter running performance in ...
The IM5 and IM6, which are already on sale in China under the names L6 and LS6, will be the vehicles taking center stage.
The 2025 MG 4 EV has got a few changes in dimensions and the overall design MG has taken over the electric vehicle market in China and is now heading towards a global influence with the MG 4 EV.
Focal’s first wireless headphones, the $699 Focal Bathys, will soon be joined by an upgraded edition called the Bathys MG. As the name suggests, the new model’s biggest improvement is the use ...
Tesla's battery-electric vehicle (BEV) registrations in 25 European Union markets, the UK, Norway and Switzerland fell on ...
Taiwan-based China Motor Corporation (CMC), a Yulon Group subsidiary, held an investor conference on March 26, addressing the ...
2d
AZoCleantech on MSNSeawater Electrolysis: A Pathway to Sustainable Mineral SynthesisSeawater electrolysis with CO2 injection enables sustainable synthesis of carbon-trapping minerals like CaCO3 and Mg(OH)2.
Soquelitinib Atopic Dermatitis Phase 1 Clinical Trial Data From Cohorts 1-3 anticipated to be Presented in MayInitial Results From First Two ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results